
Dynamin inhibitors - @ a glance
Dynamin is a key GTPase involved in various forms of endocytosis and is comprised of 3 major isoforms, all of which have four main functional domains.
In addition to being a key component of endocytosis, dynamin participates in cell cycle progression and has also been shown to have critical roles in centrosome cohesion and cytokinesis.
Dynamin inhibitors inhibit different domains of dynamin, leading to the subsequent inhibition of endocytosis. Consequently, the dynamin inhibitors have wide-spread application allowing investigation of cell signalling pathways, the cell cycle and cellular division, in addition to other medical conditions such as cancer, neurological conditions and infectious diseases such as botulism and HIV.
Interactive dynamin diagram
Role your mouse over the different domains of dynamin to see what our novel dynamin inhibitors do. Click them to find out more!
-
GTPase
RTIL-13™
Inhibition of:
Dynamin I: IC50 = 2.3 μM
OcTMAB™
Inhibition of:
Dynamin I: IC50 = 1.9 μM
Dynamin II: IC50 = 4.4 μM
MiTMAB™
Inhibition of:
Dynamin I: IC50 = 3.1 μM
Dynamin II: IC50 = 8.4 μM
-
PH
Iminodyn 17™
Inhibition of:
Dynamin I: IC50 = 330 nM
Dynamin II: IC50 = 440 nM
Iminodyn 22™
Inhibition of:
Dynamin I: IC50 = 450 nM
Dynamin II: IC50 = 390 nM
Dynole 34-2™
Inhibition of:
Dynamin I: IC50 = 1.3 μM
Dynamin II: IC50 = 14.2 μM
- AD
- PRD
Dynamin has four main functional domains; the GTPase, Pleckstrin homology (PH), Assembly domain (AD)and Proline rich domain (PRD). Different dynamin inhibitors target various sites of dynamin.
Dynamin inhibitors summary
| IC50 | ||||||
| Compound | Target Domain |
Dynamin I Inhibition (μM) |
Dynamin II Inhibition (μM) |
Synaptic Vesicle Endocytosis Endocytosis (μM) |
Receptor Mediated Endocytosis Inhibition (μM) |
Reference |
| Iminodyn-22™ | GAS | 450 | 390 | 108 | 10.7 | Hill et al 2010 |
| Imminodyn-17™ | GAS | 330 | 440 | >300 | >300 | Hill et al 2010 |
| Dynole-34-2™ | GAS | 1.3 | 14.2 | 41.1 | 5 | Hill et al 2009 |
| Dynole-31™ | GAS | >300 | Hill et al 2009 | |||
| RTIL-13™ | PH | 2.3 | 7.1 | 9.3 | Zhang et al 2008 | |
| MiTMAB™ | PH | 3.1 | 8.4 | 2.2 | 19.9 | Hill et al 2004 |
| OcTMAB™ | PH | 1.9 | 4.4 | 6.7 | Quan et al 2007 | |
| Pro-Myrisitic Acid | PH | 9.2 | >300 | Quan et al 2007 | ||
| Dyngo-4a™ | N/A | 380 nM | 2.6 nM | >300 | Harper et al 2011 | |
| Dynamin Inhibitors Toolbox | PH & GAS | |||||
| Dynamin Inhibitors: MiTMAB Series Kit | PH | |||||
| Dynamin Inhibitors: Dynole Series Kit | GAS | |||||
| Dynamin Inhibitors: Iminodyn Series Kit | GAS | |||||
References
- Hill et al (2010) Iminochromene inhibitors of dynamins I and II GTPase activity and endocytosis. J Med Chem. 53:4094-102. Abstract
- Hill et al (2009) Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indoles. J Med Chem. 25:3762-73. Abstract
- Doherty and McMahon (2009) Mechanisms of endocytosis. Annu Rev Biochem. 78:857-902. Abstract
Recommended reviews from our technical team
- Doherty and McMahon (2009) Mechanisms of endocytosis. Annu Rev Biochem. 78:857-902. Abstract
- Granseth et al (2007) Clathrin mediated endocytosis: the physiological mechanism of vesicle retrieval at hippocampal synapses. Abstract
- Mettlen et al (2009) Dissecting dynamin's role in clathrin-mediated endocytosis. Abstract
